Stock Information
Cullinan Therapeutics Inc (CGEM)
Ticker Symbol: CGEM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $852.47 mil
Piotroski score: 1
Financial data not available
Latest News
-
Wedbush Maintains Outperform on Cullinan Therapeutics, Raises Price Target to $37
Fri, May 8, 2026 9:44 AM
-
Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Thu, May 7, 2026 1:04 PM
-
Cullinan Therapeutics (NASDAQ:CGEM) Posts Narrower Q1 Loss, Eyes Key Clinical Data Catalysts
Thu, May 7, 2026 12:38 PM
-
Cullinan Therapeutics Q1 EPS $(0.75) Beats $(0.87) Estimate
Thu, May 7, 2026 8:35 AM
-
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
Thu, May 7, 2026 7:02 AM
-
Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday
Mon, May 4, 2026 9:54 AM
-
BTIG Reiterates Buy on Cullinan Therapeutics, Maintains $38 Price Target
Mon, May 4, 2026 6:15 AM
Key Financials
Financial data not available
